HopeStage
Back to all studies
TerminatedNCT00063362

Combination Therapy for the Treatment of Bipolarity

Medication studyAges 16+
The study in practice

Understand this study

Who could participate?

This study is for people with bipolarity. Listed age limits: from 16 years. Other eligibility criteria apply.

Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateFebruary 2002
Recruitment status
Terminated
Enrollment listed in the registry
49
Sponsor
University Hospitals Cleveland Medical Center
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Not clearly listed
Age range
Over 16 Years
Official registry ID
NCT00063362
Official title
Show the full official title

Combination Therapy in Bipolar Rapid Cycling

Recruitment & locations

Terminated

Locations not listed

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University Hospitals Cleveland Medical Center, a university.

Does this study involve medication?

Yes. The study involves medication, including lithium, lamotrigine, Divalproex and Placebo.

Who can participate?

This study is for people with bipolarity. Listed age limits: from 16 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies